Literature DB >> 10499512

Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences.

C Ji1, Y Chen, M Centrella, T L McCarthy.   

Abstract

Insulin-like growth factor (IGF)-binding protein-5 (IGFBP-5) has IGF-dependent and -independent actions. PGE2 rapidly increases IGFBP-5 expression by osteoblasts through cAMP-dependent processes. A minimal DNA sequence required for basal and PGE2-stimulated IGFBP-5 promoter activity spans -69 to -35 bp. This region adjoins a functional TATA box and contains E box, CCAAT enhancer-binding protein (C/EBP), nuclear factor-1 (NF-1), and activator protein-2 (AP-2) transcription factor related binding motifs. In this study we compared minimal promoter sequences of -74 to +120 bp, without or with mutations in each potential regulatory element, by reporter gene expression and electrophoretic mobility shift assays. Mutation of the E box-related element reduced basal promoter activity by 50% and eliminated the 2-fold stimulatory effect of PGE2. In contrast, mutations in the C/EBP- or NF-1-related elements also reduced basal promoter activity without fully eliminating the PGE2 effect. Overexpression of C/EBPdelta stimulated basal IGFBP-5 promoter activity, and this effect was eliminated by mutating the C/EBP-binding site. However, mutation of the AP-2-binding site or overexpression of AP-2 did not correlate with basal or PGE2-induced promoter activation. By electrophoretic mobility shift assay, prominent gel shift complexes occurred with osteoblast nuclear extracts and 32P-labeled probes spanning the E box-, C/EBP-, and NF-1-related motifs. These gel shift complexes were depleted by specific binding site mutations and were enhanced by PGE2. Increased binding by extracts from PGE2-treated cultures was blocked by cycloheximide treatment. These results identify several elements as integral binding sequences for both basal and PGE2-stimulated IGFBP-5 promoter activity. They further reveal that multiple sequences within this cluster form a basic transcription unit where nuclear factors can accumulate in a protein synthesis-dependent way and enhance IGFBP-5 expression by osteoblasts in response to PGE2.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10499512     DOI: 10.1210/endo.140.10.7061

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Decreased expression of insulin-like growth factor binding protein-5 during N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells: regulation by CCAAT/enhancer-binding protein.

Authors:  William Samuel; R Krishnan Kutty; Camasamudram Vijayasarathy; Iranzu Pascual; Todd Duncan; T Michael Redmond
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

2.  Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.

Authors:  Laura A Pérez-Casellas; Xiaoying Wang; Kristy D Howard; Mark W Rehage; Donna D Strong; Thomas A Linkhart
Journal:  Biochim Biophys Acta       Date:  2008-09-10

Review 3.  Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

Authors:  James Beattie; Gordon J Allan; Jennifer D Lochrie; David J Flint
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 4.  Biological effects and regulation of IGFBP5 in breast cancer.

Authors:  Jürgen Dittmer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

Review 5.  Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.

Authors:  Mustafa Akkiprik; Yumei Feng; Huamin Wang; Kexin Chen; Limei Hu; Aysegul Sahin; Savitri Krishnamurthy; Ayse Ozer; Xishan Hao; Wei Zhang
Journal:  Breast Cancer Res       Date:  2008-08-11       Impact factor: 6.466

6.  A hypomorphic vasopressin allele prevents anxiety-related behavior.

Authors:  Mirjam Bunck; Ludwig Czibere; Charlotte Horvath; Cornelia Graf; Elisabeth Frank; Melanie S Kessler; Chris Murgatroyd; Bertram Müller-Myhsok; Mariya Gonik; Peter Weber; Benno Pütz; Patrik Muigg; Markus Panhuysen; Nicolas Singewald; Thomas Bettecken; Jan M Deussing; Florian Holsboer; Dietmar Spengler; Rainer Landgraf
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.